Literature DB >> 16209236

[Verapamil-induced hyperprolactinemia--a case report].

Robert Krysiak1, Bogusław Okopieh, Zbigniew Stanisław Herman.   

Abstract

In many cases hyperprolactinemia can be caused by taking medications. Occasionally, verapamil-treated patients experience a slight asymptomatic increase in serum prolactin level. In this article we report the case of 42-year woman with manifest verapamil-induced hyperprolactinemia whose clinical symptoms suggested the occurrence of prolactinoma. A marked increase in prolactin levels and the preserved reactivity of this hormone in dynamic tests suggested that the patient exhibited "hypersensitivity" to verapamil. In the described state of the examined female detection of the disease, verapamil withdrawal and temporary bromocriptine administration have led to a full normalization of patient's clinical status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209236

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  1 in total

1.  Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments.

Authors:  Tae Maeshima; Ryosuke Iijima; Machiko Watanabe; Satoru Yui; Fumio Itagaki
Journal:  J Pharm Health Care Sci       Date:  2021-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.